source
- RegCell secures multi-million dollar Series A to advance Nobel-winning regulatory T-cell therapyRegCell, a biotech founded by Nobel laureate Shimon Sakaguchi, announced a new financing round to move its regulatory T-cell (Treg) program toward clinical testing. The company’s CEO Michael McCul…
- FDA approves Telix's Pixclara, first FET-PET imaging drug for glioma in the U.S.The U.S. Food and Drug Administration has granted approval to Telix Pharmaceuticals' Pixclara, a fluorine‑18 labeled amino acid PET tracer designed for imaging gliomas. This marks the first FDA‑cle…